Immunocompromised status remains a significant risk factor for in-hospital mortality in COVID-19, particularly among patients with pneumonia.

There remains much we don’t know about long covid, including its origins. It’s a complex condition likely caused by more than one thing, including a dysfunctional immune response to the earliest covid ...

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...

Researchers have developed a specialised digital framework, the COVID-19 Virus Genomics Ontology, to help scientists quickly identify and analyse viral variants through a smarter, more connected ...

Objective India had an estimated three to five million excess deaths from causes attributable to SARS-CoV-2 during 2020–2021, ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was publi ...

The American College of Physicians (ACP) has recommended that adults aged 65 years or older receive updated 2025–2026 mRNA-based COVID-19 vaccines, according to February guidelines published in Annals ...

A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has ...

The real question isn’t whether we’ll return to normal after Omicron. Rather, it is this: What will you allow your normal to be?

UB researchers said they were not able to pinpoint exactly when the variant arrived in Western New York, but it has likely ...

Objectives To examine outcomes from respiratory pathogens containment strategies focused on international travellers. Design We developed a compartmental model generalisable to respiratory infectious ...